Autonomix Medical, Inc. AMIX
1.48 USD -0.37 (-20.00%)
At closeNov 11, 2026, 7:43 PM EST
1.43 -0.05 -3.14%
After hours · Nov 11, 7:43 PM ET
1.42 Day range 1.67
1.42 52-week range 32.55
- YTD
- -87.19%
- 1 year
- -91.70%
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Lisata Therapeutics (NASDAQ:LSTA) stock rose 37.2% to $1.4 during Wednesday's regular session. The market value of their outstanding shares is at $11.0 million. BioStem Technologies…
globenewswire.com Autonomix Medical Granted New U.S. Patent Strengthening Proprietary Catheter-Based Sensing Technology Latest patent expands intellectual property protection for advanced physiological signal acquisition and processing
benzinga.com Autonomix Medical Will Be Issued U.S. Patent Number 12,793,841 Tomorrow Titled "MEDICAL DEVICES WITH CIRCUITRY FOR CAPTURING AND PROCESSING PHYSIOLOGICAL SIGNALS" https://patentcenter.uspto.gov/applications/19004748/ifw/docshttps://x.com/PatentGrants/status/2119896998711362028
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 16.2% to $4.67 during Monday's after-market session. The market value of their outstanding shares is at $9.1 million. Cerus…
globenewswire.com Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation Patent expands protection for catheter-based technologies enabling transvascular access, treatment guidance, adaptive treatment delivery, and real-time procedural validation beyond the lumen wall
benzinga.com Autonomix Medical Completes Pre-Submission Meeting With FDA For Its Transvascular Sensing Platform Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the successful completion…
globenewswire.com Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance FDA pre-submission feedback supports a Class II strategy, leveraging substantial equivalence to a previously cleared device, positioning the Company for potential initial U.S. clearance of its…
benzinga.com Autonomix Medical Receives European Patent Titled Systems For Assessing Neural Activity In An Eye Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the grant of European Patent
globenewswire.com Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform European patent strengthens protection for proprietary autonomic nervous system assessment technologies, further expanding Company's international patent portfolio
globenewswire.com Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors Appointment adds more than four decades of MedTech leadership, FDA regulatory and strategic transaction experience, including work supporting renal denervation and other category-defining technologies
globenewswire.com Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026 Abstracts highlight potential of Autonomix's transvascular technology across pain management and nervous system mapping THE WOODLANDS, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc.…
benzinga.com Autonomix Medical Announces Issuance Of U.S. Patent Titled 'Systems And Methods For Regulating Organ And/Or Tumor Growth Rates, Function, And/Or Development' On August 25 U.S. Patent No. 12,714,780 by the United States Patent and Trademark Office (USPTO), titled "Systems and Methods for Regulating Organ and/or Tumor Growth Rates, Function, and/or Development" on…
globenewswire.com Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery New patent broadens protection around systems integrating real-time physiological feedback, sensing and imaging with controlled therapeutic delivery, including neural ablation approaches for cancer…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Nuwellis (NASDAQ:NUWE) stock increased by 27.2% to $1.22 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.0 million. Summit Therapeutics…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Picard Medical (AMEX:PMI) shares moved upwards by 82.7% to $9.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.5 million. As per the news, the Q2…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 35.9% to $7.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.2 million. Biodexa…
benzinga.com Market-Moving News for August 25th AMIX: 126% | Autonomix Medical shares are trading higher ahead of the Patent and Trademark Office's decision to grant the company U.S. Patent No. 12,714,780 titled "Systems and Methods for Regulating…
benzinga.com Why Cadeler Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket Shares of Cadeler A/S (NYSE: CDLR) surged in pre-market trading after reporting strong financial results for the first half of 2026. Revenue and profit increased significantly, and full-year guidance…
benzinga.com Autonomix Medical (AMIX) Stock Surges 117% After Hours: Here’s Why Autonomix Medical shares surge 117% after hours following a $4.9 million warrant inducement deal.
globenewswire.com Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules THE WOODLANDS, TX, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Autonomix Medical (NASDAQ:AMIX) stock moved upwards by 142.1% to $13.0 during Monday's after-market session. The company's market cap stands at $5.1 million. Picard Medical (AMEX:PMI) stock…
benzinga.com Autonomix Medical Will Be Granted U.S. Patent No. 12,714,780 Tomorrow (August 25, 2026), Titled “Systems and Methods for Regulating Organ and/or Tumor Growth Rates, Function, and/or Development.” https://patentcenter.uspto.gov/applications/17971202/ifw/docs?application=
benzinga.com Autonomix Medical Q1 EPS $(5.02) Beats $(6.93) Estimate Autonomix Medical (NASDAQ:AMIX) reported quarterly losses of $(5.02) per share which beat the analyst consensus estimate of $(6.93) by 27.56 percent. This is a 77.66 percent increase over losses of…
globenewswire.com Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission Final histology and laboratory analyses support the study's safety and performance objectives THE WOODLANDS, TX, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix”…
globenewswire.com Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award Recognition honors one of the medical technology industry's most influential innovators, whose career has helped shape modern cardiovascular care
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday's regular session. The company's market cap stands at $60.6 million. Bluejay Diagnostics (NASDAQ:BJDX)…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday's pre-market session. The company's market cap stands at $1.0 million. Estrella Immunopharma…
benzinga.com Why Arista Networks Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket Arista Networks Inc (ANET) reported strong Q2 results, with revenue of $3.04B, up 37.7% YoY. Shares rose 13% in pre-market trading.
benzinga.com SpaceX, AMD, Nvidia, Astera Labs and Autonomix Medical: Why These 5 Stocks Are on Investors' Radars Today Major U.S. stock indexes finished higher on Tuesday, with the Dow Jones Industrial Average climbing 1.71% to 54,085.88.- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 42.0% to $1.42 during Tuesday's after-market session. American Well (NYSE:AMWL) stock rose 12.76% to $11.75. The market value of their…
benzinga.com Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent Autonomix Medical Inc. (NASDAQ:AMIX) shares are skyrocketing Tuesday afternoon after securing U.S. Patent No. 12,433,670.
benzinga.com Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent Autonomix Medical is skyrocketing Tuesday after securing U.S. Patent No. 12,433,670, expanding protection for its nerve-mapping platform.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular session. The company's market cap stands at $1.9 million. Adagio Medical Holdings (NASDAQ:ADGM) shares…
benzinga.com Dow Jumps Over 700 Points; Pfizer Posts Upbeat Q2 Earnings Dow rises 1.35% with technology sector leading market gains. Pfizer beats Q2 earnings expectations. Oil down 4.2%, gold up 0.8%, European markets higher.- benzinga.com Autonomix Medical Granted U.S. Patent Titled 'Systems And Methods For Treating Cancer And/Or Augmenting Organ Function' The patent expands the Company’s intellectual property protection for technologies designed to sense, map and selectively target nerves associated with tumors, cancer-related pain, organ function and…
globenewswire.com Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy Patent expands protection for technology designed to sense, map and selectively target nerves associated with tumors and cancer-related pain- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 million. Supernus…
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's after-market session. The company's market cap stands at $2.2 million. BGM Group (NASDAQ:BGM) stock…
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular session. GlucoTrack (NASDAQ:GCTK) shares moved upwards by 79.85% to $0.51. The company's market cap…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Autonomix Medical (NASDAQ:AMIX) shares increased by 89.4% to $5.21 during Wednesday's regular session. The market value of their outstanding shares is at $1.4 million. SciSparc (NASDAQ:SPRC)…
benzinga.com Dow Tumbles 400 Points; Procter & Gamble Shares Fall After Q4 Results US stocks mostly lower, Dow Jones falls 400+ pts. Energy shares up 3%. Procter & Gamble shares down 4% after worse-than-expected sales & EPS. Asian markets mixed.- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday's pre-market session. The company's market cap stands at $1.4 million. OneMedNet (NASDAQ:ONMD) shares…
benzinga.com Why Bloom Energy Shares Are Trading Higher By 11%; Here Are 20 Stocks Moving Premarket Bloom Energy Corp (BE) shares surge in pre-market trading after beating Q2 estimates and raising FY26 guidance. Other gainers include AMIX, STFS, LGHL, GMM, TURB, ONMD, VRRM, BRAI, and LVWR. Losers…
benzinga.com Autonomix Medical (AMIX) Stock Rallies Over 54% After Hours: Here's Why Autonomix Medical shares surged 54.36% after hours, reversing an intraday decline after the company disclosed warrant registration details.- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 49.1% to $4.1 during Tuesday's after-market session. The market value of their outstanding shares is at $1.5 million. CalciMedica (NASDAQ:CALC)…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Gossamer Bio (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $97.4 million. Prelude Therapeutics (NASDAQ:PRLD)…
- benzinga.com Autonomix Medical Announces Results From Preclinical Study Demonstrating Ability Of Its Neural Sensing Platform To Detect, Localize And Confirm Changes In Renal Neural Activity The study successfully demonstrated Autonomix's ability to identify neural signals associated with nerve activity along the renal artery and surrounding tissue, providing direct physiological…
globenewswire.com Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study Data demonstrate the ability to detect, localize and confirm changes in renal neural activity, supporting continued development of physiology-guided renal denervation THE WOODLANDS, TX, July 24, 2026…- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday's pre-market session. The company's market cap stands at $73.2 million. Zhengye Biotechnology…